Global and US Head of Business Operations
Robin Swartz is responsible for the overall strategy and operations of the Sanofi Genzyme Global and US Business Operations organization. She leads a team of 100 employees providing essential commercial support to all therapeutic areas. Business Operations includes activities such as forecasting, business intelligence and analytics, field force effectiveness, compliance operations and training for the Multiple Sclerosis, Rare Disease, Immunology and Oncology franchises. Robin has more than 20 years of experience in the biopharmaceutical industry and currently serves on the Sanofi Aventis Board of Directors.